|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: DETROL LA
Summary for Tradename: DETROL LA
|
| |||||||||||
Clinical Trials for: DETROL LATolterodine Drug Use Investigation.(Post Marketing Commitment Plan) Status: Completed Condition: Overactive Bladder Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder Status: Completed Condition: Overactive Bladder Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients Status: Completed Condition: Overactive Bladder Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects Status: Completed Condition: Healthy Pharmacokinetics and Relative Bioavailability Study Status: Completed Condition: Urinary Bladder, Overactive Efficacy and Safety Study of Dutasteride Combined With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) Status: Active, not recruiting Condition: BPH A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. Status: Terminated Condition: Urinary Incontinence Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet Status: Completed Condition: Urinary Incontinence Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects Status: Completed Condition: Healthy Effects Of Detrol LA On Memory And Cognition In Elderly Population Status: Completed Condition: Memory; Cognition Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 5,382,600*PED | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 6,630,162*PED | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 6,770,295*PED | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pharmacia And Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE; ORAL | 021228 | Dec 22, 2000 | RX | No | 6,911,217*PED | Y | Y | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Paragraph IV activity for: DETROL LA
| Drugname | Dosage | Strength | RLD | Submissiondate |
| tolterodine tartrate | Extended-release Capsules | 2 mg and 4 mg | Detrol LA | 7/30/2007 |
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc